200 related articles for article (PubMed ID: 23738604)
1. The association between price, competition, and demand factors on private sector anti-malarial stocking and sales in western Kenya: considerations for the AMFm subsidy.
O'Meara WP; Obala A; Thirumurthy H; Khwa-Otsyula B
Malar J; 2013 Jun; 12():186. PubMed ID: 23738604
[TBL] [Abstract][Full Text] [Related]
2. Accessibility, availability and affordability of anti-malarials in a rural district in Kenya after implementation of a national subsidy scheme.
Smith N; Obala A; Simiyu C; Menya D; Khwa-Otsyula B; O'Meara WP
Malar J; 2011 Oct; 10():316. PubMed ID: 22029829
[TBL] [Abstract][Full Text] [Related]
3. Access to artemisinin-based combination therapy (ACT) and quinine in malaria holoendemic regions of western Kenya.
Watsierah CA; Ouma C
Malar J; 2014 Jul; 13():290. PubMed ID: 25066600
[TBL] [Abstract][Full Text] [Related]
4. A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013.
Kioko U; Riley C; Dellicour S; Were V; Ouma P; Gutman J; Kariuki S; Omar A; Desai M; Buff AM
Malar J; 2016 Jul; 15(1):359. PubMed ID: 27406179
[TBL] [Abstract][Full Text] [Related]
5. Subsidising artemisinin-based combination therapy in the private retail sector.
Opiyo N; Yamey G; Garner P
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009926. PubMed ID: 26954551
[TBL] [Abstract][Full Text] [Related]
6. The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial.
Kangwana BP; Kedenge SV; Noor AM; Alegana VA; Nyandigisi AJ; Pandit J; Fegan GW; Todd JE; Brooker S; Snow RW; Goodman CA
PLoS Med; 2011 May; 8(5):e1000437. PubMed ID: 21655317
[TBL] [Abstract][Full Text] [Related]
7. Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective.
Alba S; Hetzel MW; Goodman C; Dillip A; Liana J; Mshinda H; Lengeler C
Malar J; 2010 Jun; 9():164. PubMed ID: 20550654
[TBL] [Abstract][Full Text] [Related]
8. Impact of introducing subsidized combination treatment with artemether-lumefantrine on sales of anti-malarial monotherapies: a survey of private sector pharmacies in Huambo, Angola.
Lussiana C; Floridia M; Martinho do Rosário J; Fortes F; Allan R
Trans R Soc Trop Med Hyg; 2016 Dec; 110(10):588-596. PubMed ID: 27856948
[TBL] [Abstract][Full Text] [Related]
9. Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania.
Sabot OJ; Mwita A; Cohen JM; Ipuge Y; Gordon M; Bishop D; Odhiambo M; Ward L; Goodman C
PLoS One; 2009 Sep; 4(9):e6857. PubMed ID: 19724644
[TBL] [Abstract][Full Text] [Related]
10. A pharmacy too far? Equity and spatial distribution of outcomes in the delivery of subsidized artemisinin-based combination therapies through private drug shops.
Cohen JM; Sabot O; Sabot K; Gordon M; Gross I; Bishop D; Odhiambo M; Ipuge Y; Ward L; Mwita A; Goodman C
BMC Health Serv Res; 2010 Jul; 10 Suppl 1(Suppl 1):S6. PubMed ID: 20594372
[TBL] [Abstract][Full Text] [Related]
11. Provider knowledge of treatment policy and dosing regimen with artemether-lumefantrine and quinine in malaria-endemic areas of western Kenya.
Watsierah CA; Onyango RO; Ombaka JH; Abong'o BO; Ouma C
Malar J; 2012 Dec; 11():436. PubMed ID: 23273046
[TBL] [Abstract][Full Text] [Related]
12. Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries.
O'Connell KA; Gatakaa H; Poyer S; Njogu J; Evance I; Munroe E; Solomon T; Goodman C; Hanson K; Zinsou C; Akulayi L; Raharinjatovo J; Arogundade E; Buyungo P; Mpasela F; Adjibabi CB; Agbango JA; Ramarosandratana BF; Coker B; Rubahika D; Hamainza B; Chapman S; Shewchuk T; Chavasse D
Malar J; 2011 Oct; 10():326. PubMed ID: 22039838
[TBL] [Abstract][Full Text] [Related]
13. What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism.
; Tougher S; Hanson K; Goodman C
Malar J; 2017 Apr; 16(1):173. PubMed ID: 28441956
[TBL] [Abstract][Full Text] [Related]
14. Does anti-malarial drug knowledge predict anti-malarial dispensing practice in drug outlets? A survey of medicine retailers in western Kenya.
Rusk A; Smith N; Menya D; Obala A; Simiyu C; Khwa-Otsyula B; O'Meara W
Malar J; 2012 Aug; 11():263. PubMed ID: 22866866
[TBL] [Abstract][Full Text] [Related]
15. The malaria testing and treatment landscape in Kenya: results from a nationally representative survey among the public and private sector in 2016.
; Musuva A; Ejersa W; Kiptui R; Memusi D; Abwao E
Malar J; 2017 Dec; 16(1):494. PubMed ID: 29268789
[TBL] [Abstract][Full Text] [Related]
16. Access to artemisinin-combination therapy (ACT) and other anti-malarials: national policy and markets in Sierra Leone.
Amuasi JH; Diap G; Nguah SB; Karikari P; Boakye I; Jambai A; Lahai WK; Louie KS; Kiechel JR
PLoS One; 2012; 7(10):e47733. PubMed ID: 23133522
[TBL] [Abstract][Full Text] [Related]
17. Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania.
Yadav P; Cohen JL; Alphs S; Arkedis J; Larson PS; Massaga J; Sabot O
Malar J; 2012 Aug; 11():299. PubMed ID: 22929587
[TBL] [Abstract][Full Text] [Related]
18. The effect of an anti-malarial subsidy programme on the quality of service provision of artemisinin-based combination therapy in Kenya: a cluster-randomized, controlled trial.
Kangwana BP; Kedenge SV; Noor AM; Alegana VA; Nyandigisi AJ; Pandit J; Fegan GW; Todd JE; Snow RW; Goodman CA
Malar J; 2013 Mar; 12():81. PubMed ID: 23452547
[TBL] [Abstract][Full Text] [Related]
19. Diffusion of subsidized ACTs in accredited drug shops in Tanzania: determinants of stocking and characteristics of early and late adopters.
Larson PS; Yadav P; Alphs S; Arkedis J; Massaga J; Sabot O; Cohen JL
BMC Health Serv Res; 2013 Dec; 13():526. PubMed ID: 24350611
[TBL] [Abstract][Full Text] [Related]
20. Determinants of price setting decisions on anti-malarial drugs at retail shops in Cambodia.
Patouillard E; Hanson K; Kleinschmidt I; Palafox B; Tougher S; Pok S; O'Connell K; Goodman C
Malar J; 2015 May; 14():224. PubMed ID: 26024880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
